#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3738493	B	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	Homo sapiens	40		single protein format	Scientific Literature
2.	ALA3738494	B	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	Homo sapiens	21		single protein format	Scientific Literature
3.	ALA3738495	F	Antiproliferative activity against ALK-dependent human NCI-H3122 cells after 72 hrs	Homo sapiens	21		cell-based format	Scientific Literature
4.	ALA3738496	A	Clearance in rat at 5 mg/kg, iv	Rattus norvegicus	3		organism-based format	Scientific Literature
5.	ALA3738497	A	Volume of distribution at steady state in rat at 5 mg/kg, iv	Rattus norvegicus	3		organism-based format	Scientific Literature
6.	ALA3738498	A	Half life in rat at 5 mg/kg, iv	Rattus norvegicus	3		organism-based format	Scientific Literature
7.	ALA3738502	A	Cmax in rat at 10 mg/kg, po	Rattus norvegicus	6		organism-based format	Scientific Literature
8.	ALA3738503	A	Tmax in rat at 10 mg/kg, po	Rattus norvegicus	6		organism-based format	Scientific Literature
9.	ALA3738504	A	AUC (0 to infinity) in rat at 10 mg/kg, po	Rattus norvegicus	6		organism-based format	Scientific Literature
10.	ALA3738505	A	Oral bioavailability in rat at 10 mg/kg	Rattus norvegicus	6		organism-based format	Scientific Literature
11.	ALA3738658	F	Antitumor activity against NPM-ALK-positive human KARPAS299 cells xenografted in SCID mouse assessed as decrease in tumor volume at 20 mg/kg, po qd administered for 11 days measured on day 11 post last dose	Homo sapiens	1		organism-based format	Scientific Literature
12.	ALA3738662	T	Toxicity in NPM-ALK-positive human KARPAS299 cells xenografted SCID mouse assessed as increase in body weight at 20 mg/kg, po qd administered for 11 days measured twice a week	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA3738665	T	Toxicity in NPM-ALK-positive human KARPAS299 cells xenografted SCID mouse assessed as mortality at 20 mg/kg, po qd for 11 days	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA3830294	F	Antitumor activity against mouse NIH/3T3 cells expressing wild type EML4-ALK xenografted in nude mouse assessed as tumor growth inhibition at 40 mg/kg, po qd administered for 10 days	Mus musculus	1		organism-based format	Scientific Literature
15.	ALA3830295	F	Antitumor activity against mouse NIH/3T3 cells expressing wild type EML4-ALK xenografted in nude mouse assessed as tumor growth inhibition at 20 mg/kg, po qd administered for 10 days	Mus musculus	1		organism-based format	Scientific Literature
16.	ALA3830298	F	Antitumor activity against mouse NIH/3T3 cells expressing EML4-ALK L1196M mutant xenografted in nude mouse assessed as tumor growth inhibition at 40 mg/kg, po qd administered for 10 days	Mus musculus	1		organism-based format	Scientific Literature
17.	ALA3830299	F	Antitumor activity against mouse NIH/3T3 cells expressing EML4-ALK L1196M mutant xenografted in nude mouse assessed as tumor growth inhibition at 20 mg/kg, po qd administered for 10 days	Mus musculus	1		organism-based format	Scientific Literature
18.	ALA3830300	F	Antiproliferative activity against human KARPAS299 cells after 72 hrs by SRB/CCK-8 assay	Homo sapiens	3		cell-based format	Scientific Literature
19.	ALA3830301	F	Antiproliferative activity against human SU-DHL1 cells after 72 hrs by SRB/CCK-8 assay	Homo sapiens	3		cell-based format	Scientific Literature
20.	ALA3830302	F	Antiproliferative activity against human SUP-M2 cells after 72 hrs by SRB/CCK-8 assay	Homo sapiens	3		cell-based format	Scientific Literature